Inovio Pharmaceuticals (INO) Non-Current Deffered Revenue (2010 - 2022)
Inovio Pharmaceuticals (INO) recorded Non-Current Deffered Revenue of $56,935 in Q2 2022, down 20.7% from $71,788 a year earlier and down 6.1% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends
At the end of FY2021, Inovio Pharmaceuticals reported Non-Current Deffered Revenue of $64,361, down 18.8% from FY2020.
- Annual Non-Current Deffered Revenue has declined for five straight years, with a five-year compound annual growth rate of -27.3% (FY2016 to FY2021).
- Across earlier years, Non-Current Deffered Revenue came in at $79,214 in FY2020 (-22.0%), $101,567 in FY2019 (-32.6%), $150,793 in FY2018 (-30.1%) and $215,853 in FY2017 (-32.1%).
- The Q2 2022 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2010.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for 15 consecutive quarters, with an average decline of 21.8% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 16.7% in Q3 2018, against a decline of 55.0% in Q3 2017 at the low end.
- Per Business Quant, the preceding three quarters came in at $60,648 (Q1 2022), $64,361 (Q4 2021) and $68,075 (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Inovio Pharmaceuticals | 98.76 Mn | 98.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 56,935.00 |
| Mar 31, 2022 | 60,648.00 |
| Dec 31, 2021 | 64,361.00 |
| Sep 30, 2021 | 68,075.00 |
| Jun 30, 2021 | 71,788.00 |
| Mar 31, 2021 | 75,501.00 |
| Dec 31, 2020 | 79,214.00 |
| Sep 30, 2020 | 82,927.00 |
| Jun 30, 2020 | 86,641.00 |
| Mar 31, 2020 | 100,354.00 |
| Dec 31, 2019 | 101,567.00 |
| Sep 30, 2019 | 124,105.00 |
| Jun 30, 2019 | 116,630.00 |
| Mar 31, 2019 | 141,803.00 |
| Dec 31, 2018 | 150,793.00 |
| Sep 30, 2018 | 192,034.00 |
| Jun 30, 2018 | 175,157.00 |
| Mar 31, 2018 | 203,322.00 |
| Dec 31, 2017 | 215,853.00 |
| Sep 30, 2017 | 164,604.00 |
API Access
Inovio Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();